SEC Form 4 · accession 0001127602-16-048303

CONMED Corp · CNMD

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Mark D Snyder

Officer — EVP Mfg. Ops & Business System

Period of report

Mar 31, 2016

Accepted (ET)

Apr 4, 2016 · 2:10 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0000816956

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common Stock	Mar 31, 2016	M	1,200	$0.00	A	15,462	D
Common Stock	Mar 31, 2016	F	329	$41.94	D	15,133	D
Common Stock	Mar 31, 2016	M	800	$0.00	A	15,933	D
Common Stock	Mar 31, 2016	F	219	$41.94	D	15,714	D
Common Stock	Mar 31, 2016	M	1,600	$0.00	A	17,314	D
Common Stock	Mar 31, 2016	F	438	$41.94	D	16,876	D
Common Stock	Mar 31, 2016	M	2,400	$0.00	A	19,276	D
Common Stock	Mar 31, 2016	F	657	$41.94	D	18,619	D
Common Stock	Mar 31, 2016	M	2,080	$0.00	A	20,699	D
Common Stock	Mar 31, 2016	F	569	$41.94	D	20,130	D

Table II — derivative securities

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Rsus (restricted Stock Units)^F1	$0.00	Mar 31, 2016	M	1,200	D	—	Jun 1, 2020	Common Stock	1,200	0	D
Rsus (restricted Stock Units)^F2	$0.00	Mar 31, 2016	M	800	D	—	Jun 1, 2021	Common Stock	800	0	D
Rsus (restricted Stock Units)^F2	$0.00	Mar 31, 2016	M	1,600	D	—	Jun 1, 2022	Common Stock	1,600	0	D
Rsus (restricted Stock Units)^F2	$0.00	Mar 31, 2016	M	2,400	D	—	Jun 1, 2023	Common Stock	2,400	0	D
Rsus (restricted Stock Units)^F2	$0.00	Mar 31, 2016	M	2,080	D	—	Jun 1, 2024	Common Stock	2,080	0	D
Rsus (restricted Stock Units)^F3	$0.00	Mar 31, 2016	D	900	D	—	Feb 27, 2025	Common Stock	900	0	D
Sars (Stock Appreciation Rights)^F4	$44.90	Mar 31, 2016	D	5,200	D	—	Jun 1, 2024	Common Stock	5,200	1,300	D
Sars (Stock Appreciation Rights)^F5	$51.30	Mar 31, 2016	D	16,480	D	—	Feb 27, 2025	Common Stock	16,480	4,120	D

Explanation of responses

F1Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 1999 Amended and Restated Long-Term Incentive Plan, with the RSUs vesting over a seven year period with 14% of the RSU's vesting in the first through the fifth year after the grant date and 15% vesting in the sixth and seventh year.
F2Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 1999 Amended and Restated Long-Term Incentive Plan, with the RSUs generally vesting over a five year period with the first 20% of the RSU's vesting one year after the grant date.
F3Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 1999 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts (25%) over a four year period.
F4The stock appreciation rights ("SARs") were granted under the Company's 1999 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period.
F5The stock appreciation rights ("SARs") were granted under the Company's 1999 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts (20%) over a five year period.